Aggeliki Dasoula

644 total citations
16 papers, 420 citations indexed

About

Aggeliki Dasoula is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Aggeliki Dasoula has authored 16 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Hematology and 6 papers in Genetics. Recurrent topics in Aggeliki Dasoula's work include Epigenetics and DNA Methylation (5 papers), Acute Myeloid Leukemia Research (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Aggeliki Dasoula is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Acute Myeloid Leukemia Research (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Aggeliki Dasoula collaborates with scholars based in Greece, Canada and United Kingdom. Aggeliki Dasoula's co-authors include Eleftheria Hatzimichael, Konstantinos L. Bourantas, Leonidas Benetatos, Maria Syrrou, Ioannis Georgiou, George Dranitsaris, Tim Crook, Stavroula Tsiara, Nelofer Syed and Justin Stebbing and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Fertility and Sterility.

In The Last Decade

Aggeliki Dasoula

16 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aggeliki Dasoula Greece 9 333 197 81 75 35 16 420
Albert Gründer Germany 8 331 1.0× 53 0.3× 72 0.9× 70 0.9× 44 1.3× 12 429
Kelly Milton United States 6 403 1.2× 125 0.6× 37 0.5× 167 2.2× 54 1.5× 11 537
Elizabeth J. Heller United States 6 541 1.6× 45 0.2× 147 1.8× 83 1.1× 90 2.6× 6 856
Trisha A. Macrae United States 6 435 1.3× 66 0.3× 94 1.2× 52 0.7× 25 0.7× 8 537
Sara Montagner Italy 9 274 0.8× 131 0.7× 85 1.0× 25 0.3× 19 0.5× 10 482
Kimberly R. Blahnik United States 7 691 2.1× 104 0.5× 91 1.1× 83 1.1× 33 0.9× 7 782
Patrick A. Ozark United States 13 619 1.9× 66 0.3× 73 0.9× 61 0.8× 65 1.9× 15 754
Borko Tanasijevic Canada 14 500 1.5× 55 0.3× 113 1.4× 67 0.9× 65 1.9× 17 599
Christina Manetopoulos Sweden 8 276 0.8× 75 0.4× 17 0.2× 36 0.5× 110 3.1× 8 377
Kelly Arndt United States 10 255 0.8× 40 0.2× 45 0.6× 120 1.6× 43 1.2× 17 378

Countries citing papers authored by Aggeliki Dasoula

Since Specialization
Citations

This map shows the geographic impact of Aggeliki Dasoula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aggeliki Dasoula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aggeliki Dasoula more than expected).

Fields of papers citing papers by Aggeliki Dasoula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aggeliki Dasoula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aggeliki Dasoula. The network helps show where Aggeliki Dasoula may publish in the future.

Co-authorship network of co-authors of Aggeliki Dasoula

This figure shows the co-authorship network connecting the top 25 collaborators of Aggeliki Dasoula. A scholar is included among the top collaborators of Aggeliki Dasoula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aggeliki Dasoula. Aggeliki Dasoula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hatzimichael, Eleftheria, et al.. (2015). Expression Profiling of a Panel of Apoptosis Related Micrornas in Patients with Acute Myeloid Leukemia. Blood. 126(23). 4971–4971. 1 indexed citations
2.
Hatzimichael, Eleftheria, Aggeliki Dasoula, Leonidas Benetatos, et al.. (2012). Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications. Leukemia & lymphoma. 53(9). 1709–1713. 12 indexed citations
3.
Hatzimichael, Eleftheria, Aggeliki Dasoula, Nelofer Syed, et al.. (2012). Epigenetic inactivation to target the arginine biosynthetic pathway in multiple myeloma.. Journal of Clinical Oncology. 30(15_suppl). e18567–e18567. 1 indexed citations
4.
Benetatos, Leonidas, Aggeliki Dasoula, Eleftheria Hatzimichael, et al.. (2011). Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions. Annals of Hematology. 90(9). 1037–1045. 28 indexed citations
5.
Voutsinas, Gerassimos E., Eleana F. Stavrou, Aggeliki Dasoula, et al.. (2010). Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease. Human Mutation. 31(6). 685–691. 47 indexed citations
6.
Hatzimichael, Eleftheria, Aggeliki Dasoula, Leonidas Benetatos, et al.. (2010). Study of specific genetic and epigenetic variables in multiple myeloma. Leukemia & lymphoma. 51(12). 2270–2274. 26 indexed citations
7.
Hatzimichael, Eleftheria, Aggeliki Dasoula, George Dranitsaris, et al.. (2010). BIK (Bcl2-Interacting Killer) CpG methylation status as a potential predictive biomarker of relapsed/refractory multiple myeloma disease.. Journal of Clinical Oncology. 28(15_suppl). 8118–8118. 1 indexed citations
8.
Benetatos, Leonidas, Eleftheria Hatzimichael, Aggeliki Dasoula, et al.. (2009). CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leukemia Research. 34(2). 148–153. 124 indexed citations
9.
Hatzimichael, Eleftheria, Leonidas Benetatos, Aggeliki Dasoula, et al.. (2009). Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia. Leukemia Research. 33(9). 1272–1275. 11 indexed citations
10.
Hatzimichael, Eleftheria, Aggeliki Dasoula, Nelofer Syed, et al.. (2009). The prolyl‐hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia. European Journal Of Haematology. 84(1). 47–51. 39 indexed citations
11.
Hatzimichael, Eleftheria, George Dranitsaris, Aggeliki Dasoula, et al.. (2009). von Hippel–Lindau Methylation Status in Patients with Multiple Myeloma: A Potential Predictive Factor for the Development of Bone Disease. Clinical Lymphoma & Myeloma. 9(3). 239–242. 29 indexed citations
12.
Hatzimichael, Eleftheria, Aggeliki Dasoula, Justin Stebbing, et al.. (2009). DNA methylation status of Smurf2 promoter in patients with multiple myeloma. Journal of Clinical Oncology. 27(15_suppl). e19537–e19537. 1 indexed citations
13.
Dasoula, Aggeliki, Sophia Kalantaridou, Alexandros Sotiriadis, et al.. (2008). Skewed X-Chromosome Inactivation in Greek Women with Idiopathic Recurrent Miscarriage. Fetal Diagnosis and Therapy. 23(3). 198–203. 5 indexed citations
14.
Benetatos, Leonidas, Aggeliki Dasoula, Eleftheria Hatzimichael, et al.. (2008). Promoter Hypermethylation of the MEG3 (DLK1/MEG3) Imprinted Gene in Multiple Myeloma. Clinical Lymphoma & Myeloma. 8(3). 171–175. 80 indexed citations
15.
Dasoula, Aggeliki, et al.. (2007). Methylation status of the SNRPN and HUMARA genes in testicular biopsy samples. Fertility and Sterility. 87(4). 805–809. 7 indexed citations
16.
Tzoufi, Meropi, Aggeliki Dasoula, Ioannis Asproudis, et al.. (2007). Mosaic Trisomy r(14) Associated With Epilepsy and Mental Retardation. Journal of Child Neurology. 22(7). 869–873. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Albert Gründer Breakdown of academic impact, for papers by Kelly Milton Breakdown of academic impact, for papers by Elizabeth J. Heller Breakdown of academic impact, for papers by Trisha A. Macrae Breakdown of academic impact, for papers by Sara Montagner Breakdown of academic impact, for papers by Kimberly R. Blahnik Breakdown of academic impact, for papers by Patrick A. Ozark Breakdown of academic impact, for papers by Borko Tanasijevic Breakdown of academic impact, for papers by Christina Manetopoulos Breakdown of academic impact, for papers by Kelly Arndt
Rankless by CCL
2026